(PharmaNewsWire.Com, September 15, 2017 ) The North America Protein A Market is exhibiting evident potential in the forecasting period. Increasing research on monoclonal antibodies is expected to drive the sales of Protein A resins.
Monoclonal antibodies can be defined as an antibody produced by a single clone of cells; they antibodies can be produced in large quantities in the laboratory. They can be used to carry drugs, toxins, or radioactive substances straight to cancer cells. Monoclonal antibodies have been showing promising results in the management of chronic diseases such as cancers and rheumatoid arthritis.
North America Protein A Resins Market is driven by factors as growing demand for biosimilars and increasing investments in the development of biosimilar products whereas rising awareness about alternate methods to purify monoclonal antibodies is expected to restrain the Protein A Resins market growth. High cost associated with the Protein A resin is also a major factor hindering the market growth.
North American market for Protein A resin is segmented by product type, application, matrix type and end user. Based on product it is further classified as Natural Protein A Resin and Recombinant Protein A Resin. Recombinant Protein A segment is estimated to be the fastest growing product segment. On the basis of application protein A resin market is segmented as Immunoprecipitation and Antibody Purification. Within this segment immunoprecipitation is estimated to be the fastest growing. By Matrix type global Protein A Resin market is analyzed as Glass or Silica, Agarose and Organic Polymer. By matrix type agarose accounts for the largest share and is estimated to continue its strong hold during the forecast period. By end user Protein A Resin market is segmented as Biopharmaceutical Manufacturers, Clinical Research Laboratories and Academic Institutions
Geographically North America Protein A resin market segmented into two regions namely United States and Canada. Within North America, United States is the largest market for Protein A resin accounting for a share of approximately XX% while Canada is estimated to be the fastest growing region.
Major Players in the market are entering into strategic agreements to develop raw materials required manufacture Protein A resins. Some of the key companies covered in the report are GE Healthcare, Repligen Corporation, Novasep, Tosoh Bioscience, GenScript, Thermo Fisher Scientific, EMD Millipore and Expedeon Ltd.
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
